From Name:
From Email:
To Name:
To Email:

Optional Message:

2-drug combination may boost immunotherapy responses in lung cancer patients

from Johns Hopkins University School of Medicine via Medical Xpress

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, achieved robust anti-tumor responses in human cancer cell lines and mice. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063